SCALA, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 2.010
AS - Asia 1.294
EU - Europa 568
SA - Sud America 205
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 4.099
Nazione #
US - Stati Uniti d'America 1.920
SG - Singapore 617
CN - Cina 369
IT - Italia 240
BR - Brasile 160
IN - India 123
VN - Vietnam 115
SE - Svezia 101
DE - Germania 85
CA - Canada 65
GB - Regno Unito 61
FI - Finlandia 25
MX - Messico 19
AR - Argentina 16
BD - Bangladesh 11
UA - Ucraina 11
HK - Hong Kong 10
ZA - Sudafrica 10
EC - Ecuador 9
ID - Indonesia 7
CL - Cile 6
ES - Italia 6
JP - Giappone 6
KR - Corea 6
RO - Romania 6
RU - Federazione Russa 6
VE - Venezuela 5
FR - Francia 4
IQ - Iraq 4
NL - Olanda 4
PL - Polonia 4
EU - Europa 3
PE - Perù 3
PY - Paraguay 3
TH - Thailandia 3
TR - Turchia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AT - Austria 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
EE - Estonia 2
IR - Iran 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
UY - Uruguay 2
UZ - Uzbekistan 2
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NI - Nicaragua 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.099
Città #
Chandler 323
Singapore 249
Dallas 207
Ashburn 126
Santa Clara 106
Milan 99
Bengaluru 97
Hefei 97
Lawrence 96
Princeton 96
San Jose 96
Munich 80
London 52
Ottawa 51
Wilmington 50
Chicago 49
Beijing 47
Ho Chi Minh City 45
Des Moines 39
Catanzaro 31
Shanghai 25
Los Angeles 24
Turku 24
Hanoi 17
São Paulo 17
Guangzhou 16
Napoli 16
Boardman 15
Seattle 11
Hong Kong 10
New York 10
Brooklyn 9
San Francisco 9
Redmond 8
Rio de Janeiro 8
Haiphong 7
Marano 7
Mexico City 7
Pune 7
Da Nang 6
Montreal 6
Mumbai 6
Seoul 6
Shenzhen 6
Boston 5
Stockholm 5
Tokyo 5
Xi'an 5
Augusta 4
Columbus 4
Foggia 4
Jiaxing 4
Latina 4
Luni 4
Naples 4
Norwalk 4
Timisoara 4
Warsaw 4
Ann Arbor 3
Asunción 3
Atlanta 3
Bangkok 3
Biên Hòa 3
Campinas 3
Cape Town 3
Chieti 3
Derby 3
Dhaka 3
Ferrara 3
Guayaquil 3
Johannesburg 3
Las Vegas 3
Ninh Bình 3
Oklahoma City 3
Reggio Calabria 3
The Dalles 3
Amsterdam 2
Ankara 2
Arequipa 2
Benito Juarez 2
Betim 2
Buffalo 2
Cagliari 2
Caracas 2
Charlotte 2
Clearwater 2
Cosenza 2
Council Bluffs 2
Curitiba 2
Dalian 2
Dalmine 2
Denver 2
Dubai 2
Edmonton 2
Hangzhou 2
Hải Dương 2
Limeira 2
Lowell 2
Manaus 2
Manchester 2
Totale 2.475
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 134
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 94
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. 88
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 79
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 76
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 73
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 73
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 70
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43 68
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 66
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 65
Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65 65
Inhibition of HIV-1 replication in primary human monocytes by the IkappaB-alfaS32/36A repressor of NF-kappaB 64
Cancer-associated CD43 glycoforms as target of immunotherapy 64
The aftermath of the Merck's HIV vaccine trial 63
IkappaB-alpha Represses the Transcriptional Activity of the HIV-1 Tat Transactivator by Promoting Its Nuclear Export 63
B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy 62
Computational analysis and in vivo validation of a microRNA encoded by the IBTK gene, a regulator of B-lymphocytes differentiation and survival 61
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 60
Cancer-associated CD43 glycoforms as target of immunotherapy 58
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 56
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 54
Diminished active T rosette levels and increased spontaneous B lymphocyte blastogenesis in hepatitis B virus positive chronic active hepatitis 54
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 53
A new strategy for label-free detection of lymphoma cancer cells 53
High attenuation and immunogenicity of a simian immunodeficiency virus expressing a proteolysis-resistant inhibitor of NF-kappa B 52
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 50
AUTOCRINE GROWTH-FUNCTION OF HUMAN INTERLEUKIN-1 MOLECULES 49
An NF-κB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-κB-activating stimuli 49
High efficiency of site-directed mutagenesis mediated by a single PCR product 48
Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein 47
SUBSETS OF HUMAN LARGE GRANULAR LYMPHOCYTES (LGL) EXHIBIT ACCESSORY CELL FUNCTIONS 45
Epstein-Barr Virus Nuclear Antigen 2 transactivates the Long Terminal Repeat of Human Immunodeficiency Virus Type 1 45
Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors 45
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 45
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 45
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 44
HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enancer-binding protein beta (NF-IL6) transcription factors 43
Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line 43
Ultraviolet Mutagenesis 43
Regulation of the HIV Promoter/Enhancer 42
Spontaneous and mutagen-mediated amplification of a neo gene integrated at different genomic sites in Rat 2 fibroblasts 41
Regulation of NF-kappa B through the nuclear processing of p105 (NF-kappa B1) in Epstein-Barr virus-immortalized B cell lines 40
Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle 40
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 40
Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1 40
DECREASED INTERLEUKIN-1 PRODUCTION IN APLASTIC-ANEMIA 39
Structural and functional insights into IκB-α/HIV-1 Tat interaction. 39
MIND THE MOUSE - A CONSENSUS VIEW ON THE USE OF IMMUNODEFICIENT MICE IN IMMUNOLOGY AND ONCOLOGY 39
Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line 38
A NF-KAPPA-B-BINDING SITE IN TAR ENHANCES THE HIV-1 GENE-EXPRESSION IN RESPONSE TO NF-KAPPA-B ACTIVATING STIMULI 38
Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context 38
HETEROGENEITY IN THE MITOGENIC RESPONSE OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO A PAN-T MONOCLONAL-ANTIBODY 38
LYMPHOKINE ABNORMALITIES IN APLASTIC-ANEMIA - IMPLICATIONS FOR THE MECHANISM OF ACTION OF ANTITHYMOCYTE GLOBULIN 37
Multimodal Imaging for a Theranostic Approach in a Murine Model of B-cell Lymphoma with Engineered Nanoparticles 37
Regulation of HIV-long terminal repeats by interactionof C/EBP(NF-IL6) and NF-kB/rel transcription factors 36
MUTAGENS ENHANCE THE HIV-1, INTERLEUKIN-1 (IL-1), AND INTERLEUKIN-6 (IL-6) EXPRESSION THROUGH TRANSCRIPTIONAL OR POSTTRANSCRIPTIONAL MECHANISMS 36
TNF-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes 36
Peptide-guided targeting of GPR55 for anti-cancer therapy. 36
SEQUENTIAL INDUCTION OF C-MYC AND C-FOS MESSENGER-RNA TRANSCRIPTS DURING OKT3-INDUCED ACTIVATION OF T-CELLS 35
Identification of a Btk-BAG3 complex induced by oxidative stress 35
EFFECT OF INTERLEUKIN-1-BETA ON TRANSDUCING MECHANISMS IN 235-1 CLONAL PITUITARY-CELLS .1. MODULATION OF ADENYLATE-CYCLASE ACTIVITY 34
EFFECT OF INTERLEUKIN-1-BETA ON TRANSDUCING MECHANISMS IN 235-1 CLONAL PITUITARY-CELLS .2. MODULATION OF CALCIUM FLUXES 34
HEMODIALYSIS RELATED INDUCTION OF INTERLEUKIN-6 PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS 34
Induction of tumorigenicity and plasmacytoid differentiation in EBV-B cells by expression of exogenous interleukin-6 or IL-6 receptor genes. 34
Perspectives for a protective HIV-1 vaccine 33
HUMAN INTERLEUKIN-1 (IL1) STIMULATES THE GROWTH OF ROHA-9, AN EBV-TRANSFORMED HUMAN B-CELL LINE 32
INHIBITION BY ANTI-HLA CLASS-II MONOCLONAL-ANTIBODIES OF MONOCYTE-DEPENDENT T-CELL PROLIFERATION INDUCED BY MONOCLONAL-ANTIBODY OKT3 32
THE HIV-1 TAT PROTEIN TRANSACTIVATES THE INTERLEUKIN-6 GENE 31
INTERLEUKIN-INDUCED TUMOR IMMUNOGENICITY 31
Impaired generation of bone marrow B lymphocytes in mice deficient of C/EBPbeta 31
The Human Immunodeficiency Virus Type 1 Long Terminal Repeat is activated by monofunctional and bifunctional DNA alkylating agents in human lymphocytes 31
EFFECTS OF RECOMBINANT INTERFERON-GAMMA ON HLA-DR ANTIGEN SHEDDING BY HUMAN PERIPHERAL-BLOOD ADHERENT MONONUCLEAR-CELLS 30
Site-directed mutagenesis mediated by a single polymerase chain reaction product 30
Identification and functional characterization of antigenic mimotopes of surface immunoglobulin from transformed B cells 30
IMMUNOSUPPRESSIVE ACTIVITY OF BOVINE SEMINAL RNASE ON T-CELL PROLIFERATION 29
Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk 29
FUNCTIONAL INTERACTIONS OF NF-KAPPA-B FACTORS WITH NF-IL6-C/EBP TRANSCRIPTION FACTORS IN THE REGULATION OF HIV-1 LTR 28
PRODUCTION OF INTERLEUKIN-1 ACTIVITY BY NORMAL HUMAN PERIPHERAL-BLOOD LYMPHOCYTE-B 27
HUMAN INTERLEUKIN-1 (IL-1) IS THE AUTOSTIMULATORY GROWTH-FACTOR FOR ROHA-9, AN EBV-TRANSFORMED HUMAN B-CELL LINE 27
REARRANGEMENT LEADING TO THE EXPRESSION OF A PROMOTERLESS NEO GENE SPONTANEOUSLY OR FOLLOWING MUTAGENIC TREATMENTS IN STABLY TRANSFORMED RAT-2 FIBROBLASTS 27
Human large granular lymphocytes are potent producers of interleukin-1 26
INTERLEUKIN-1-BETA MODULATION OF PROLACTIN SECRETION FROM RAT ANTERIOR-PITUITARY-CELLS - INVOLVEMENT OF ADENYLATE-CYCLASE ACTIVITY AND CALCIUM MOBILIZATION 26
The expression of the Interleukin-6 gene is induced by the human immunodeficiency virus Tat Protein 25
Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappa B (I kappa B-alpha S32/36A) and the implications for vaccine development 23
EXPRESSION OF INTERLEUKINS IN L-CELLS TRANSFECTED WITH HUMAN DNA 22
Peptide-guided targeting of GPR55 for anti-cancer therapy 22
Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures. 21
Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes 21
INTERLEUKIN-6 (IL6) INDUCES PLASMACYTOID DIFFERENTIATION OF EBV-B CELLS TRANSFECTED WITH AN IL6 RECEPTOR GENE 21
Predictive value of Epstein-Bar virus genome copy number and BZLF1 expression in blood lyphocytes of transplant recipients at risk for lymphoproliferative disease 20
THE EXPRESSION OF THE INTERLEUKINS GENE IS INDUCED BY THE HUMAN IMMUNODEFICIENCY VIRUS-1 TAT PROTEIN 20
DNA-DAMAGING AGENTS INCREASE THE STABILITY OF INTERLEUKIN-1-ALPHA, INTERLEUKIN-1-BETA, AND INTERLEUKIN-6 TRANSCRIPTS AND THE PRODUCTION OF THE RELATIVE PROTEINS 18
Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity. 18
PRODUCTION OF MULTIPLE CYTOKINES BY CLONES OF HUMAN LARGE GRANULAR LYMPHOCYTES 15
Shc mediates IL-6 signaling by interacting with gp130 and Jaj2 kinase 15
Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1 positive sera 14
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 12
null 6
Totale 4.168
Categoria #
all - tutte 45.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 12 0 19 18 1 1
2021/2022324 4 2 3 78 24 5 10 99 14 38 44 3
2022/2023865 192 24 34 62 103 91 3 67 170 59 46 14
2023/2024305 66 41 27 22 25 77 2 7 1 4 11 22
2024/20251.119 170 66 96 37 88 127 19 21 160 35 104 196
2025/20261.362 112 223 283 297 228 100 119 0 0 0 0 0
Totale 4.168